![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PPIL4 |
Gene summary for PPIL4 |
![]() |
Gene information | Species | Human | Gene symbol | PPIL4 | Gene ID | 85313 |
Gene name | peptidylprolyl isomerase like 4 | |
Gene Alias | HDCME13P | |
Cytomap | 6q25.1 | |
Gene Type | protein-coding | GO ID | GO:0000413 | UniProtAcc | Q8WUA2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
85313 | PPIL4 | P54T-E | Human | Esophagus | ESCC | 3.13e-23 | 5.32e-01 | 0.0975 |
85313 | PPIL4 | P56T-E | Human | Esophagus | ESCC | 2.69e-07 | 1.06e+00 | 0.1613 |
85313 | PPIL4 | P57T-E | Human | Esophagus | ESCC | 8.63e-12 | 3.19e-01 | 0.0926 |
85313 | PPIL4 | P61T-E | Human | Esophagus | ESCC | 1.39e-15 | 3.15e-01 | 0.099 |
85313 | PPIL4 | P62T-E | Human | Esophagus | ESCC | 2.16e-19 | 2.93e-01 | 0.1302 |
85313 | PPIL4 | P65T-E | Human | Esophagus | ESCC | 1.07e-21 | 3.32e-01 | 0.0978 |
85313 | PPIL4 | P74T-E | Human | Esophagus | ESCC | 8.21e-29 | 8.17e-01 | 0.1479 |
85313 | PPIL4 | P75T-E | Human | Esophagus | ESCC | 6.66e-35 | 6.25e-01 | 0.1125 |
85313 | PPIL4 | P76T-E | Human | Esophagus | ESCC | 3.70e-30 | 5.67e-01 | 0.1207 |
85313 | PPIL4 | P79T-E | Human | Esophagus | ESCC | 3.20e-30 | 5.67e-01 | 0.1154 |
85313 | PPIL4 | P80T-E | Human | Esophagus | ESCC | 2.54e-25 | 7.44e-01 | 0.155 |
85313 | PPIL4 | P82T-E | Human | Esophagus | ESCC | 1.14e-25 | 8.24e-01 | 0.1072 |
85313 | PPIL4 | P83T-E | Human | Esophagus | ESCC | 4.33e-29 | 8.36e-01 | 0.1738 |
85313 | PPIL4 | P84T-E | Human | Esophagus | ESCC | 1.57e-03 | 4.66e-01 | 0.0933 |
85313 | PPIL4 | P89T-E | Human | Esophagus | ESCC | 7.48e-08 | 6.18e-01 | 0.1752 |
85313 | PPIL4 | P91T-E | Human | Esophagus | ESCC | 9.44e-16 | 9.56e-01 | 0.1828 |
85313 | PPIL4 | P107T-E | Human | Esophagus | ESCC | 1.98e-26 | 5.60e-01 | 0.171 |
85313 | PPIL4 | P126T-E | Human | Esophagus | ESCC | 3.16e-06 | 6.33e-01 | 0.1125 |
85313 | PPIL4 | P127T-E | Human | Esophagus | ESCC | 6.89e-08 | 1.33e-01 | 0.0826 |
85313 | PPIL4 | P128T-E | Human | Esophagus | ESCC | 2.54e-31 | 8.81e-01 | 0.1241 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001820816 | Esophagus | ESCC | peptidyl-proline modification | 46/8552 | 58/18723 | 1.59e-07 | 2.51e-06 | 46 |
GO:000041313 | Esophagus | ESCC | protein peptidyl-prolyl isomerization | 32/8552 | 42/18723 | 5.52e-05 | 4.27e-04 | 32 |
GO:00708161 | Esophagus | ESCC | phosphorylation of RNA polymerase II C-terminal domain | 12/8552 | 12/18723 | 8.21e-05 | 6.01e-04 | 12 |
GO:00182084 | Liver | Cirrhotic | peptidyl-proline modification | 26/4634 | 58/18723 | 6.65e-04 | 5.04e-03 | 26 |
GO:00004132 | Liver | Cirrhotic | protein peptidyl-prolyl isomerization | 19/4634 | 42/18723 | 3.00e-03 | 1.71e-02 | 19 |
GO:001820811 | Liver | HCC | peptidyl-proline modification | 42/7958 | 58/18723 | 3.73e-06 | 4.85e-05 | 42 |
GO:00004131 | Liver | HCC | protein peptidyl-prolyl isomerization | 31/7958 | 42/18723 | 3.83e-05 | 3.80e-04 | 31 |
GO:001820810 | Skin | cSCC | peptidyl-proline modification | 37/4864 | 58/18723 | 1.53e-09 | 5.82e-08 | 37 |
GO:00004136 | Skin | cSCC | protein peptidyl-prolyl isomerization | 26/4864 | 42/18723 | 9.92e-07 | 1.78e-05 | 26 |
GO:007081611 | Skin | cSCC | phosphorylation of RNA polymerase II C-terminal domain | 11/4864 | 12/18723 | 3.30e-06 | 5.08e-05 | 11 |
GO:001820817 | Thyroid | PTC | peptidyl-proline modification | 42/5968 | 58/18723 | 2.71e-10 | 8.91e-09 | 42 |
GO:00004137 | Thyroid | PTC | protein peptidyl-prolyl isomerization | 30/5968 | 42/18723 | 1.65e-07 | 3.13e-06 | 30 |
GO:001820818 | Thyroid | ATC | peptidyl-proline modification | 42/6293 | 58/18723 | 1.70e-09 | 4.21e-08 | 42 |
GO:000041314 | Thyroid | ATC | protein peptidyl-prolyl isomerization | 30/6293 | 42/18723 | 6.06e-07 | 8.44e-06 | 30 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PPIL4 | SNV | Missense_Mutation | rs769253589 | c.721N>A | p.Val241Ile | p.V241I | Q8WUA2 | protein_coding | deleterious(0.04) | benign(0.152) | TCGA-BH-A202-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
PPIL4 | SNV | Missense_Mutation | rs755983989 | c.181N>T | p.Arg61Cys | p.R61C | Q8WUA2 | protein_coding | tolerated(0.08) | possibly_damaging(0.877) | TCGA-E2-A15H-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | herceptin | SD |
PPIL4 | SNV | Missense_Mutation | c.1293G>T | p.Lys431Asn | p.K431N | Q8WUA2 | protein_coding | tolerated(0.14) | probably_damaging(0.95) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
PPIL4 | SNV | Missense_Mutation | rs761631618 | c.1334N>A | p.Arg445Gln | p.R445Q | Q8WUA2 | protein_coding | tolerated(0.12) | benign(0.078) | TCGA-C5-A8XH-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
PPIL4 | SNV | Missense_Mutation | c.389N>T | p.Thr130Ile | p.T130I | Q8WUA2 | protein_coding | deleterious(0) | possibly_damaging(0.701) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
PPIL4 | SNV | Missense_Mutation | c.991T>C | p.Tyr331His | p.Y331H | Q8WUA2 | protein_coding | tolerated(0.24) | probably_damaging(0.973) | TCGA-AA-3950-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
PPIL4 | SNV | Missense_Mutation | c.989N>C | p.Lys330Thr | p.K330T | Q8WUA2 | protein_coding | tolerated(0.2) | benign(0.154) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
PPIL4 | SNV | Missense_Mutation | c.991N>A | p.Tyr331Asn | p.Y331N | Q8WUA2 | protein_coding | tolerated(0.07) | probably_damaging(0.973) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
PPIL4 | SNV | Missense_Mutation | c.563G>T | p.Ser188Ile | p.S188I | Q8WUA2 | protein_coding | deleterious(0.02) | possibly_damaging(0.841) | TCGA-D5-6930-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
PPIL4 | deletion | Frame_Shift_Del | novel | c.897_898delNN | p.Phe299LeufsTer9 | p.F299Lfs*9 | Q8WUA2 | protein_coding | TCGA-AA-A01D-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | capecitabine | PD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |